Central Diabetes Insipidus as a Manifestation of AML Secondary to Temodar Therapy for Pancreatic Neuroendocrine Tumor

Kansas Journal of Medicine
doi 10.17161/kjm.v4i3.11359
Full Text
Abstract

Available in full text

Date
Authors
Publisher

The University of Kansas

Related search

A Case of Ectopic Growth Hormone Releasing Hormone (GHRH) From Pancreatic Neuroendocrine Tumor Resistant to Therapy

Open Journal of Endocrine and Metabolic Diseases
2013English

A Case of Central Diabetes Insipidus: Evaluation in Pregnancy

International Journal of Clinical Medicine
2011English

Efficacy of Indapamide in Central Diabetes Insipidus

Archives of Internal Medicine
1999English

Diagnosis and Management of Central Diabetes Insipidus in Adults

Clinical Endocrinology
EndocrinologyMetabolismDiabetes
2018English

Infundibuloneurohypophysitis as a Cause of Central Diabetes Insipidus in an Indian Woman Two Years Postpartum

Journal of the ASEAN Federation of Endocrine Societies
EndocrinologyMetabolismDiabetes
2012English

Opsoclonus as a Paraneoplastic Manifestation of Pancreatic Carcinoma

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
1997English

Glucocorticoid-Induced Central Diabetes Insipidus in a Case of Malignant Lymphoma.

Tohoku Journal of Experimental Medicine
BiochemistryMedicineGeneticsMolecular Biology
1991English

Gastric Gastrointestinal Stromal Tumor and Neuroendocrine Pancreatic Tumor: Always Neurofibromatosis?

Endoscopic Ultrasound
HepatologyNuclear MedicineRadiologyImagingGastroenterology
2014English

Partial Central Diabetes Insipidus Complicating Nonketotic Hyperglycemic Hyperosmolar Coma

Journal of the American Osteopathic Association, The
MedicineAlternative MedicineComplementary
1996English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy